CLCD

CoLucid Pharmaceuticals

NASDAQ

Add Alert

CLCD

CoLucid Pharmaceuticals

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

stocktrademan Free

12/01/16 12:03 PM

Post #53

CLCD bullish 35.10

possibly an ascending triangle breakout soon

normal chart

log chart

stocktrademan Free

11/20/16 10:44 AM

Post #52

CLCD bullish 36.45

normal chart

log chart

kei

11/14/16 6:02 PM

Post #51

Re: #50: @DewDiligence - Yes—2Q17 is what the PR says.

thank you dew :)
i think one analyst indicated pt $52 here - is that if good data?
still holding shares in your charitable account?

DewDiligence PremiumMember

11/14/16 5:59 PM

Post #50

Re: #49: @kei - hi dew :) when are you expecting P3

Yes—2Q17 is what the PR says.

kei

11/14/16 5:28 PM

Post #49

Re: #48: @DewDiligence - CLCD has enrolled >50% of 2,968 target in

hi dew :) when are you expecting P3 data? i thought 2Q 2017?

DewDiligence PremiumMember

11/14/16 9:21 AM

Post #48

Re: #21: @DewDiligence - CLCD reports positive phase-3 data from SAMURAI study:

CLCD has enrolled >50% of 2,968 target in SPARTAN phase-3 trial:

http://finance.yahoo.com/news/colucid-pharmaceuticals-provides-spartan-enrollment-130000943.html

Please see #msg-124979400 for related info.

DewDiligence PremiumMember

11/09/16 8:19 AM

Post #47

CLCD had $100.2M cash at 9/30/16: #msg-126424565.

DewDiligence PremiumMember

10/31/16 9:28 AM

Post #46

Re: #21: @DewDiligence - CLCD reports positive phase-3 data from SAMURAI study:

Bullish write-up on CLCD:

http://www.bionapcfa.com/2016/10/why-after-massive-run-colucid-shares.html

stocktrademan Free

10/13/16 11:50 AM

Post #45

Re: #43: @stocktrademan - long-term stock account scan CLCD bullish 33.27

CLCD bullish 36.99

increase position since it is profiting so far
buy more shares of stocks showing positive returns

normal chart

log chart

DewDiligence PremiumMember

10/05/16 12:05 PM

Post #44

Re: #37: @DewDiligence - Positive secondary endpoints from SAMURAI study: #msg-125220925.

CLCD reports additional data from SAMURAI study:

http://finance.yahoo.com/news/colucid-pharmaceuticals-announces-additional-analyses-145443436.html

stocktrademan Free

09/26/16 12:41 PM

Post #43

long-term stock account scan CLCD bullish 33.27

normal chart

log chart

kei

09/19/16 12:09 PM

Post #42

Re: #41: @DewDiligence - Another all-time high today (eom).

money printing machine wink

DewDiligence PremiumMember

09/19/16 11:13 AM

Post #41

Re: #38: @kei - CLCD Ladenburg Thalmann making positive comments,

Another all-time high today (eom).

DewDiligence PremiumMember

09/19/16 11:12 AM

Post #40

Re: #37: @DewDiligence - Positive secondary endpoints from SAMURAI study: #msg-125220925.

CLCD reports update from GLADIATOR safety study: #msg-125245097.

BioSpecialist Free

09/19/16 10:23 AM

Post #39

Shorted this Junk again at $31 the stock is brutally overbought and i dont see any potential in their migraine drug which is still years away from the market IF ever . The Market is overflooded with very very cheap generic drugs for migraine so how they will make money ?

Without the almost zero interest and massive printing of worthless dollars by FED Mafia then such scams would not trade at these astronomical levels . The whole stock market is a mega bubble which is close to implode .

kei

09/19/16 8:06 AM

Post #38

Re: #37: @DewDiligence - Positive secondary endpoints from SAMURAI study: #msg-125220925.

CLCD Ladenburg Thalmann making positive comments, PT $57, ph 3 data detail bolsters Lasmiditan. Firm believes M&A is a possibility

DewDiligence PremiumMember

09/17/16 11:26 AM

Post #37

Re: #21: @DewDiligence - CLCD reports positive phase-3 data from SAMURAI study:

Positive secondary endpoints from SAMURAI study: #msg-125220925.

DewDiligence PremiumMember

09/15/16 4:55 PM

Post #36

All-time intra-day and closing highs today.

kei

09/15/16 1:13 PM

Post #35

Re: #34: @DewDiligence - CLCD’s largest shareholder, NVO, bought $2M of stock

CLCD..more detailed data (Samurai) will be presented this Sunday

DewDiligence PremiumMember

09/13/16 12:03 PM

Post #34

CLCD’s largest shareholder, NVO, bought $2M of stock in CLCD’s 9/9/16 public offering:

https://www.sec.gov/Archives/edgar/data/1348649/000120919116141046/xslF345X03/doc4.xml

NVO has close to a 20% stake in CLCD.

DewDiligence PremiumMember

09/08/16 4:10 PM

Post #33

CLCD selling unspecified amount of stock on unspecified terms:

http://finance.yahoo.com/news/colucid-pharmaceuticals-announces-proposed-public-200100048.html

nyctraydr

09/07/16 4:00 PM

Post #32

Here’s The Latest From CoLucid's Lasmiditan Clinical Study http://marketexclusive.com/heres-latest-colucid-pharmaceuticals-inc-nasdaqclcd-lasmiditan-clinical-study/32120/?icd1

WovenO2

09/07/16 8:43 AM

Post #31

26! Premarket...WOW!!!

zumantu

09/07/16 8:32 AM

Post #30

Re: #22: @DewDiligence - CLCD new corporate slide set:

Dew, what's your expectation on mkt cap value, fully realized potential ?

cjstocksup PremiumMember

09/06/16 8:20 PM

Post #29

Re: #28: @crudeoil24 - CLCD moved up nicely in AH.

I was wondering why CLCD was moving up a bit premarket this AM in about the first half hour but another C stock was up about 100% soI figured that was it until KABOOM! Once the markets opened we ran HUGE on the news and I was alsleep. I figured I would make a bit from those early pre market shares but nothing compared to what we ended up at. I just got lucky.

crudeoil24 PremiumMember

09/06/16 8:16 PM

Post #28

Re: #26: @cjstocksup - CLCD early pre market was so beautiful. I

CLCD moved up nicely in AH.

DewDiligence PremiumMember

09/06/16 4:16 PM

Post #27

Re: #26: @cjstocksup - CLCD early pre market was so beautiful. I

+124% on the day—not bad.

cjstocksup PremiumMember

09/06/16 4:06 PM

Post #26

Re: #25: @crudeoil24 - Shorts having their way now.

CLCD early pre market was so beautiful. I was thinking we would run when I went for it but over 100% is awesome. Congrats to everyone who was awake early as I was. Awesome gainer day.

crudeoil24 PremiumMember

09/06/16 2:54 PM

Post #25

Re: #24: @BioSpecialist - What a fantastic SHORT opp here ..Another Phase

Shorts having their way now.

BioSpecialist Free

09/06/16 1:20 PM

Post #24

What a fantastic SHORT opp here ..Another Phase 3 is required and they running out of cash another point is tha the market is full of very very cheap generics for Migraine

Garagebux

09/06/16 12:12 PM

Post #23

weeee

DewDiligence PremiumMember

09/06/16 11:10 AM

Post #22

Re: #21: @DewDiligence - CLCD reports positive phase-3 data from SAMURAI study:

CLCD new corporate slide set:

https://t.co/EvjDJv73Cm

DewDiligence PremiumMember

09/06/16 9:54 AM

Post #21

CLCD reports positive phase-3 data from SAMURAI study:

#msg-124979400

north40000 PremiumMember

09/06/16 8:36 AM

Post #20

CLCD: + $7.64 at $18.40 PM

Jonlilie

08/31/16 6:37 PM

Post #19

Re: #18: @DewDiligence - Who said the news is going to be positive?

Valid point. Assuming the uptrend, and three variables of partially proven drug lasmiditan, also the scheduled presentation the the 17th? What am I missing

DewDiligence PremiumMember

08/31/16 6:33 PM

Post #18

Re: #17: @Jonlilie - I saw that but it seems odd that

Who said the news is going to be positive?

Jonlilie

08/31/16 6:31 PM

Post #17

Re: #16: @DewDiligence - It's 10b5-1 (i.e. automated) selling—see the Form-4 footnote.

I saw that but it seems odd that his shares would be automatically sold if good news was coming next week. He had 15000 shares as of March and has been dumping in 508 blocks, prior to these smaller sells. Why wouldn't the head of Pharma hold out for positive news?

DewDiligence PremiumMember

08/31/16 6:29 PM

Post #16

Re: #15: @Jonlilie - Any reason why Raymond would continue to unload shares?

It's 10b5-1 (i.e. automated) selling—see the Form-4 footnote.

Jonlilie

08/31/16 6:22 PM

Post #15

Any reason why Raymond would continue to unload shares?

ChikiTiny

08/29/16 11:27 AM

Post #14

Re: #13: @DewDiligence - CLCD had $41.8M cash at 6/30/16—a decline of

nice pop on no news in CLCD...runup into anticipated data I presume...

DewDiligence PremiumMember

08/10/16 9:25 AM

Post #13

Re: #7: @DewDiligence - Cash at 3/31/16 was $54.1M:

CLCD had $41.8M cash at 6/30/16—a decline of $12.3M relative to 3/31/16:

http://finance.yahoo.com/news/colucid-pharmaceuticals-announces-2016-second-120000956.html

tjguy

06/30/16 1:10 AM

Post #12

Results in August or September, not July. Sorry.

From the June 7th press release:

CAMBRIDGE, Mass., June 07, 2016 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (Nasdaq:CLCD), a Phase 3 clinical-stage biopharmaceutical company that is developing lasmiditan oral tablets for the acute treatment of migraine in adults, announced today that the last patient has been randomized in its SAMURAI study, the Company’s first Phase 3 pivotal trial of lasmiditan. Per the SAMURAI protocol, the last patient randomized will have up to eight weeks to complete the study. SAMURAI top-line data are expected to be released when available in the third quarter of 2016, with more detailed results to be presented at a symposium during the 5th European Headache and Migraine Trust International Congress (EHMTIC 2016) taking place in Glasgow, Scotland on September 17th, 2016.

I expect stock appreciation to rise in anticipation of good results.